WHO selects vaccines, therapeutics for field trials against Ebola Bundibugyo outbreak in DRC (bioworld.com)

• WHO selects vaccines and therapeutics for field trials against Ebola Bundibugyo.
• Ervebo is among the selected candidates, despite no approval for Bundibugyo.
• Outbreak in DRC; no approved vaccines or treatments available.

"The WHO has selected vaccines and therapeutics, including Ervebo, for field trials against the current Ebola Bundibugyo outbreak in the Democratic Republic of Congo. No approved vaccines or treatments exist for the Bundibugyo virus. The selection aims to test potential cross-protection or novel candidates."